Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Option Care Health is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- DEFA14A2026-10-06DEFA14A
- DEFA14A2026-10-06DEFA14A
- 8-K2026-10-06Current report (material event)
- SCHEDULE 13G/A2026-08-14SCHEDULE 13G/A
- 10-Q2026-07-29Quarterly report
- 8-K2026-07-29Current report (material event)
- 8-K2026-05-22Current report (material event)
- 8-K2026-05-12Current report (material event)
- SCHEDULE 13G/A2026-05-06SCHEDULE 13G/A
- 8-K2026-05-05Current report (material event)
- 10-Q2026-04-30Quarterly report
- SCHEDULE 13G2026-04-30SCHEDULE 13G
- 8-K2026-04-30Current report (material event)
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- ARS2026-04-08Annual report to holders
- DEFA14A2026-04-08DEFA14A
- DEF 14A2026-04-08Proxy statement
- 8-K2026-04-02Current report (material event)
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- 10-K2026-02-24Annual report
- 8-K2026-02-24Current report (material event)
- 8-K2026-01-12Current report (material event)
- SCHEDULE 13G2025-11-05SCHEDULE 13G
- 10-Q2025-10-30Quarterly report
- 8-K2025-10-30Current report (material event)
- 8-K2025-09-25Current report (material event)
- 8-K2025-08-20Current report (material event)
- SCHEDULE 13G/A2025-08-12SCHEDULE 13G/A
- 10-Q2025-07-30Quarterly report
- 8-K2025-07-30Current report (material event)
- SCHEDULE 13G2025-06-13SCHEDULE 13G
- 8-K2025-05-16Current report (material event)
- 10-Q2025-04-29Quarterly report
- 8-K2025-04-29Current report (material event)
- ARS2025-04-02Annual report to holders
- DEFA14A2025-04-02DEFA14A
- DEF 14A2025-04-02Proxy statement
- PRE 14A2025-03-19PRE 14A
- 10-K2025-02-26Annual report
- 8-K2025-02-26Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.